Recruiting Revumenib in Combination With 7+3 + Midostaurin in AML NCT06313437 Conditions AML, AML With Gene Mutations, AML, Adult, +8 more Locations Yale Cancer Center — New Haven, Connecticut, United States Dana-Farber Cancer Institute — Boston, Massachusetts, United States View Trial Details
Recruiting Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia NCT06366789 Conditions AML With Gene Mutations Locations University of California, Los Angeles — Los Angeles, California, United States University of California, San Francisco — San Francisco, California, United States Emory University — Atlanta, Georgia, United States The University of Chicago — Chicago, Illinois, United States View all 23 locations View more locations Show fewer locations Loading locations... View Trial Details
